biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
企業コードBTMD
会社名Biote Corp
上場日Mar 02, 2021
設立日2020
最高経営責任者「CEO」Mr. Bret Christensen
従業員数217
証券種類Ordinary Share
決算期末Mar 02
本社所在地1875 W. Walnut Hill Ln #100
都市IRVING
証券取引所NASDAQ Global Market Consolidated
国United States of America
郵便番号75038
電話番号19724869346
ウェブサイトhttps://haymakeracquisition.com/
企業コードBTMD
上場日Mar 02, 2021
設立日2020
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし